Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Fielmann Group AGXSWX:FIE 86 EV-to-EBITDA is 8.22 as of Jul. 19, 2026, which is 45% below its 10-year median of 14.86. GuruFocus rates XSWX:FIE with a GF Score™ of 86/100 and a GF Value™ of CHF49.97. The stock has 2 warning signs investors should review. Among 510 Medical Devices & Instruments companies, Fielmann Group AG ranks better than 73.92% on this metric.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Fielmann Group AG's enterprise value is CHF3,685 Mil.
Fielmann Group AG's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 was CHF449 Mil. Therefore, Fielmann Group AG's EV-to-EBITDA for today is 8.22.
The historical rank and industry rank for Fielmann Group AG's EV-to-EBITDA or its related term are showing as below:
XSWX:FIE'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 6.94 Med: 14.86 Max: 27.7
Current: 8.27
During the past 13 years, the highest EV-to-EBITDA of Fielmann Group AG was 27.70. The lowest was 6.94. And the median was 14.86.
XSWX:FIE's EV-to-EBITDA is ranked better than 73.92% of 510
companies
in the Medical Devices & Instruments industry
Industry Median: 14.155
vs XSWX:FIE: 8.27
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio (TTM).
Fielmann Group AG (XSWX:FIE) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Fielmann Group AG's PE Ratio (TTM) for today is calculated as:
Fielmann Group AG's share price for today is CHF37.15.
Fielmann Group AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF2.303.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
The historical data trend for Fielmann Group AG's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:FIE vs ISRG, BDX, MDLN: EV-to-EBITDA Comparison
For the Medical Instruments & Supplies subindustry, Fielmann Group AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Fielmann Group AG EV-to-EBITDA vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Fielmann Group AG's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Fielmann Group AG's EV-to-EBITDA falls into.
Fielmann Group AG's current Enterprise Value is CHF3,685 Mil.
Fielmann Group AG's EBITDA for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was CHF449 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Fielmann Group AG (XSWX:FIE) has a EV-to-EBITDA of 8.22 as of Jul. 19, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Fielmann Group AG. This is 45% below median its historical median of 14.86. Over the past decade, Fielmann Group AG's EV-to-EBITDA has ranged from 6.94 to 27.70. According to the industry distribution chart, Fielmann Group AG ranks #133 out of 510 companies in the Medical Devices & Instruments industry, placing it in the top 26.1%.
Is Fielmann Group AG's EV-to-EBITDA too high?
Fielmann Group AG's current EV-to-EBITDA of 8.22 is 45% below median its 10-year median of 14.86. Over the past 10 years, this metric has ranged from a low of 6.94 to a high of 27.70. The Medical Devices & Instruments industry median EV-to-EBITDA is 14.16. Fielmann Group AG's value of 8.22 is 41.9% below this industry median. Based on the distribution chart, Fielmann Group AG ranks #133 out of 510 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Fielmann Group AG has a GF Score™ of 86/100, reflecting its overall financial health beyond just this single metric.
How does Fielmann Group AG's EV-to-EBITDA compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Fielmann Group AG ranks #133 out of 510 companies for EV-to-EBITDA. This puts Fielmann Group AG in the upper half of its industry. The industry median EV-to-EBITDA is 14.16. Fielmann Group AG's value of 8.22 is 41.9% below this benchmark. Historically, Fielmann Group AG's own EV-to-EBITDA has ranged from 6.94 to 27.70 over the past decade. While the company's 10-year median is 14.86 vs. the industry median of 14.16, Fielmann Group AG has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Medical Devices & Instruments company?
The median EV-to-EBITDA among Medical Devices & Instruments companies is 14.16, based on 510 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Fielmann Group AG's current EV-to-EBITDA of 8.22 is 41.9% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Fielmann Group AG. For the Medical Devices & Instruments industry, the median EV-to-EBITDA is 14.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Fielmann Group AG's current EV-to-EBITDA is 8.22, which is 45% below median its own 10-year median of 14.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Fielmann Group AG stock overvalued right now?
Fielmann Group AG (XSWX:FIE) has a current EV-to-EBITDA of 8.22. The stock's GF Value™ is CHF49.97, compared to a current price of CHF37.15 — trading 25.7% below its estimated fair value. The current EV-to-EBITDA is 8.22, which is 45% below median its 10-year median of 14.86 and 41.9% below the Medical Devices & Instruments industry median of 14.16. Fielmann Group AG's overall GF Score™ is 86/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Fielmann Group AG (XSWX:FIE), the current EV-to-EBITDA is 8.22 as of Jul. 19, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Fielmann Group AG (XSWX:FIE) Overvalued in 2026?
Based on GuruFocus' analysis, Fielmann Group AG stock appears to be undervalued.
The current stock price of CHF37.15 is trading 25.7% below its estimated GF Value™ of CHF49.97.
Key valuation signals for XSWX:FIE:
EV-to-EBITDA: 8.22 (45% below median its 10-year median of 14.86)
GF Value™: CHF49.97 vs. price of CHF37.15 (25.7% below fair value)
Industry Position: 41.9% below the Medical Devices & Instruments median (#133 of 510)
No single metric tells the full story. See the XSWX:FIE stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Fielmann Group AG is involved in the purchase and sale of goods, in physical stores as well as wholesale and online, particularly in the optometric and hearing acoustics sectors, and especially sales of all kinds of vision aids - particularly glasses, eyeewear frames and lenses, sunglasses, contact lenses, accessories, hearing systems, as well as personal protective equipment. Fielmann is involved in all levels of the optical industry value-added chain: designing, manufacturing, product offering, and optician services. The group was divided into six segments: Germany, Switzerland, Austria, Spain, North America, and Other. The majority of its revenue is generated from Germany.
86GF Score
Get the complete analysis for XSWX:FIE
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:FIE has been successfully added to your 
